Nine Test Pr Rich Insights into Plaque Psoriasis Market, Patient Pool, Pipeline Therapies, Key Companies working in the Space and Emerging Trends

Nine test Pr Rich Insights into Plaque Psoriasis Market, Patient Pool, Pipeline Therapies, Key Companies working in the Space and Emerging Trends 

DelveInsight’s Plaque Psoriasis Market Insights Report offers a detailed analysis of disease, its causes, symptoms, diagnostics modalities and treatment options.

The report also offers comprehensive insights into Plaque Psoriasis market size, epidemiology, emerging therapies, market drivers, market barriers, ongoing clinical trials, key collaboration in the space, and key pharmaceutical companies actively pushing the growth of market size forward.

Some of the key highlights from the Plaque Psoriasis Market Insights: 

• According to National Psoriasis Foundation (NPF), more than 8 million Americans have psoriasis and is equally prevalent in males and females.
• The most common form of psoriasis, affecting about 80 to 90 per cent of psoriasis patients, is plaque psoriasis.
• Plaque psoriasis is the most common form of the disease, affecting 80 per cent of those with psoriasis.
• At present, there is no cure in the Plaque Psoriasis market.
• The Plaque Psoriasis Therapeutics market comprises topical agents such as moisturizers, vitamin D creams, topical retinoids, and medications such as TAZORAC®, Duobrii (Ortho Dermatologics), and coal tar.
• TAZORAC (Allergan, Inc) Gel, 0.05%, and 0.1% is indicated for the topical treatment of patients with plaque psoriasis of up to 20% body surface area involvement.
• Major players such as Bristol-Myers Squibb, Dermavant Sciences GmbH, Arcutis, Inc., Avillion LLP, and others are involved in developing therapies for the treatment and management of Plaque Psoriasis. These therapies are currently under different stages of development.
• Key pipeline therapies in the Plaque Psoriasis market include Tapinarof (Dermavant Sciences GmbH), BMS986165 (Bristol-Myers Squibb),  ARQ-151 (Arcutis, Inc.) and M1095 (Avillion LLP), among others.

Learn more by requesting for sample @ Plaque Psoriasis Market Landscape

Plaque Psoriasis: Overview 

Psoriasis is a common skin condition that speeds up the life cycle of skin cells. It causes cells to build up rapidly on the surface of the skin. The extra skin cells form scales and red patches that are itchy and sometimes painful.

The characteristic signs and symptoms of psoriasis are small scaly, red bumps. These bumps generally join together into elevated plaques of skin and most often are visible on the elbows, knees, and scalp, although any area of skin can be involved. Frequently, these plaques are quite itchy. Rarely, most of the patient’s skin surface is affected.

For more insights into Disease, causes and treatment, reach out @ Plaque Psoriasis Treatment Landscape 

Plaque Psoriasis Epidemiology Segmentation 

The Plaque Psoriasis Market report proffers epidemiological analysis for the study period 2017-30 in the 7MM segmented into:

• Psoriasis Prevalence
• Plaque Psoriasis Prevalence
• Severity Specific Plaque Psoriasis Prevalence
• Diagnosed and Treatable Cases of Plaque Psoriasis

Visit for more @ Plaque Psoriasis Epidemiological Insights 

Plaque Psoriasis Market 

Plaque Psoriasis Market size is expected to expand owing to the launch of several emerging therapies, key companies working in the space, rising prevalence, increment in R&D in the field, medical advancements happening in the Plaque Psoriasis market domain.

Plaque Psoriasis Pipeline Therapies and Key Companies

• Tapinarof: Dermavant Sciences GmbH
• BMS986165: Bristol-Myers Squibb
• ARQ-151: Arcutis
• M1095: Avillion

For more information, visit Plaque Psoriasis Market Analysis, Patient Pool and Emerging Therapies 

Plaque Psoriasis Market Drivers

• Rising prevalent population
• Technological advancements
• Emerging therapies
• Extensive R&D

Scope of the Report

• 11 Years Forecast
• 7MM Coverage
• Descriptive overview of Plaque Psoriasis, covering causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
• Comprehensive insight into Plaque Psoriasis epidemiology and treatment in the 7MM
• Current and emerging therapies for Plaque Psoriasis
• Plaque Psoriasis market drivers and barriers

Key Questions Answered in the Report

• What was the Plaque Psoriasis market share (%) distribution in 2017 and how it would look like in 2030?
• What would be the Plaque Psoriasis total market size as well as market size by therapies across the 7MM during the forecast period (2017-2030)?
• What are the key findings pertaining to the market across 7MM and which country will have the largest Plaque Psoriasis market size during the forecast period (2017-2030)?
• At what CAGR, the Plaque Psoriasis market is expected to grow in 7MM during the forecast period (2017-2030)?

Get in touch with our Business executive @ Plaque Psoriasis Market Landscape Analysis 

Table of Contents 

Learn more about the report offerings @ Plaque Psoriasis Market Outlook

Related Reports

Glioblastoma Multiforme Market

DelveInsight’s ‘Glioblastoma Multiforme (GBM) Market Insights, Epidemiology and Market Forecast– 2030’ report.

Glioma Market

DelveInsight’s “Glioma Market Insights, Epidemiology, and Market Forecast-2030” report.

Gliosarcoma Market

DelveInsight’s “Gliosarcoma Market Insights, Epidemiology, and Market Forecast-2030” report.

High-Grade Glioma Market

DelveInsight’s ‘High-grade Glioma (HGG) Market Insights, Epidemiology and Market Forecast – 2030’ report.

Malignant Glioma Market

DelveInsight’s “Malignant Glioma Market Insights, Epidemiology, and Market Forecast-2030” report.

About DelveInsight 

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences providing end-to-end comprehensive solutions to improve their performance.

Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Contact Information: